Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study.
Phase of Trial: Phase II
Latest Information Update: 09 Dec 2016
At a glance
- Drugs Carboplatin (Primary) ; Ixabepilone (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms ECLIPSE
- 10 Jun 2017 Biomarkers information updated
- 20 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Dec 2011 A poster on this trial will be presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, according to a McKesson Specialty Health media release.